Cyclic AMP and Ca2+ uptake by mastocytoma mitochondria

Area of Science:

• Cell Biology
• Biochemistry
• Mitochondrial Function

Background:

• N6, O2'-dibutyryladenosine-3',5'-cyclic monophosphate (DB cyclic AMP) treatment affects PY815 cells.
• Mitochondrial calcium (Ca2+) uptake is a critical cellular process.

Purpose of the Study:

• To re-investigate factors potentially explaining increased 45Ca2+ uptake by mitochondria in DB cyclic AMP-treated PY815 cells.
• To clarify the role of mitochondria in regulating cytoplasmic Ca2+ availability and cell growth.

Main Methods:

• Isolation of mitochondria from DB cyclic AMP-treated and untreated PY815 cells.
• Measurement of 45Ca2+ uptake rates and total Ca2+ content in isolated mitochondria.
• Assessment of Ca2+ leakage from precharged mitochondria.
• Quantification of total cellular Ca2+ content.

Main Results:

• Mitochondria from DB cyclic AMP-treated cells exhibited a 30% faster initial rate of 45Ca2+ uptake compared to controls.
• Filtration artifacts led to an overestimation of 45Ca2+ uptake in treated cell mitochondria.
• Mitochondria and whole cells from DB cyclic AMP-treated cells contained less total Ca2+ than untreated cells.
• Slower Ca2+ leakage was observed from precharged mitochondria of treated cells.

Conclusions:

• The apparent increased mitochondrial Ca2+ uptake is an artifact of the experimental procedure.
• Mitochondria do not play a significant role in controlling DB cyclic AMP-treated PY815 cell growth via cytoplasmic Ca2+ availability.
• DB cyclic AMP treatment leads to a reduction in overall cellular and mitochondrial calcium levels.